{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:25:01Z","timestamp":1783488301551,"version":"3.55.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T00:00:00Z","timestamp":1618617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T00:00:00Z","timestamp":1618617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100009687","name":"Uniwersytet Medyczny im. Piast\u00f3w Slaskich we Wroclawiu","doi-asserted-by":"publisher","award":["STM.C120.16.016"],"award-info":[{"award-number":["STM.C120.16.016"]}],"id":[{"id":"10.13039\/501100009687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-021-01565-w","type":"journal-article","created":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T20:02:21Z","timestamp":1618689741000},"page":"2475-2484","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Effect of systemic steroid therapy in Graves\u2019 orbitopathy on regulatory T cells and Th17\/Treg ratio"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2153-1583","authenticated-orcid":false,"given":"M.","family":"Siomkaj\u0142o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141.","family":"Mizera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Szymczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kola\u010dkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Grzegrz\u00f3\u0142ka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bolanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Daroszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,17]]},"reference":[{"key":"1565_CR1","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41433-018-0279-9","volume":"33","author":"Y Huang","year":"2019","unstructured":"Huang Y, Fang S, Li D, Zhou H, Li B, Fan X (2019) The involvement of T cell pathogenesis in thyroid-associated ophthalmopathy. Eye 33:176\u2013182","journal-title":"Eye"},{"key":"1565_CR2","first-page":"134","volume":"22","author":"P Fasching","year":"2017","unstructured":"Fasching P, Stradner M, Graninger W, Dejaco C, Fessler J (2017) Therapeutic potential of targeting the Th17\/Treg axis in autoimmune disorders. Mol Basel Switz 22:134","journal-title":"Mol Basel Switz"},{"key":"1565_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s12020-015-0759-7","volume":"52","author":"R Gonz\u00e1lez-Amaro","year":"2016","unstructured":"Gonz\u00e1lez-Amaro R, Marazuela M (2016) T regulatory (Treg) and T helper 17 (Th17) lymphocytes in thyroid autoimmunity. Endocrine 52:30\u201338","journal-title":"Endocrine"},{"key":"1565_CR4","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1507\/endocrj.EJ16-0108","volume":"63","author":"K Matsuzawa","year":"2016","unstructured":"Matsuzawa K, Izawa S, Okura T, Fujii S, Matsumoto K, Shoji K, Nakamura R, Sumi K, Fujioka Y, Yoshida A, Shigemasa C, Kato M et al (2016) Implications of FoxP3-positive and -negative CD4+ CD25+ T cells in Graves’ ophthalmopathy. Endocr J 63:755\u2013764","journal-title":"Endocr J"},{"key":"1565_CR5","doi-asserted-by":"publisher","first-page":"e340934","DOI":"10.1155\/2015\/340934","volume":"2015","author":"P Pawlowski","year":"2015","unstructured":"Pawlowski P, Wawrusiewicz-Kurylonek N, Eckstein A, Reszec J, Luczynski W, Johnson K, Kretowski A, Bakunowicz-Lazarczyk A, Gorska M, Szamatowicz J, Chyczewski L, Mysliwiec J (2015) Disturbances of modulating molecules (FOXP3, CTLA-4\/CD28\/B7, and CD40\/CD40L) mRNA expressions in the orbital tissue from patients with severe Graves\u2019 ophthalmopathy. Mediators Inflamm 2015:e340934","journal-title":"Mediators Inflamm"},{"key":"1565_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.autrev.2014.10.011","volume":"14","author":"MG Petrillo","year":"2015","unstructured":"Petrillo MG, Ronchetti S, Ricci E, Alunno A, Gerli R, Nocentini G, Riccardi C (2015) GITR+ regulatory T cells in the treatment of autoimmune diseases. Autoimmun Rev 14:117\u2013126","journal-title":"Autoimmun Rev"},{"key":"1565_CR7","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.lfs.2017.11.026","volume":"192","author":"S Shao","year":"2018","unstructured":"Shao S, Yu X, Shen L (2018) Autoimmune thyroid diseases and Th17\/Treg lymphocytes. Life Sci 192:160\u2013165","journal-title":"Life Sci"},{"key":"1565_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1365-2249.2006.03316.x","volume":"148","author":"RS Douglas","year":"2007","unstructured":"Douglas RS, Gianoukakis AG, Goldberg RA, Kamat S, Smith TJ (2007) Circulating mononuclear cells from euthyroid patients with thyroid-associated ophthalmopathy exhibit characteristic phenotypes. Clin Exp Immunol 148:64\u201371","journal-title":"Clin Exp Immunol"},{"key":"1565_CR9","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1210\/jc.2016-1882","volume":"101","author":"S Fang","year":"2016","unstructured":"Fang S, Huang Y, Wang S, Zhang Y, Luo X, Liu L, Zhong S, Liu X, Li D, Liang R, Miranda P, Gu P et al (2016) IL-17A exacerbates fibrosis by promoting the proinflammatory and profibrotic function of orbital fibroblasts in TAO. J Clin Endocrinol Metab 101:2955\u20132965","journal-title":"J Clin Endocrinol Metab"},{"key":"1565_CR10","doi-asserted-by":"publisher","first-page":"e609593","DOI":"10.1155\/2015\/609593","volume":"2015","author":"J Shen","year":"2015","unstructured":"Shen J, Li Z, Li W, Ge Y, Xie M, Lv M, Fan Y, Chen Z, Zhao D, Han Y (2015) Th1, Th2, and Th17 cytokine involvement in thyroid associated ophthalmopathy. Dis Markers 2015:e609593","journal-title":"Dis Markers"},{"key":"1565_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2017.12.007","volume":"87","author":"R Stadhouders","year":"2018","unstructured":"Stadhouders R, Lubberts E, Hendriks RW (2018) A cellular and molecular view of T helper 17 cell plasticity in autoimmunity. J Autoimmun 87:1\u201315","journal-title":"J Autoimmun"},{"key":"1565_CR12","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1210\/jc.2017-01349","volume":"102","author":"S Fang","year":"2017","unstructured":"Fang S, Huang Y, Zhong S, Li Y, Zhang Y, Li Y, Sun J, Liu X, Wang Y, Zhang S, Xu T, Sun X et al (2017) Regulation of orbital fibrosis and adipogenesis by pathogenic Th17 cells in Graves orbitopathy. J Clin Endocrinol Metab 102:4273\u20134283","journal-title":"J Clin Endocrinol Metab"},{"key":"1565_CR13","doi-asserted-by":"publisher","first-page":"6123","DOI":"10.1167\/iovs.16-20199","volume":"57","author":"S Fang","year":"2016","unstructured":"Fang S, Huang Y, Zhong S, Zhang Y, Liu X, Wang Y, Gu P, Zhou H, Fan X (2016) IL-17A Promotes RANTES Expression, But Not IL-16, in Orbital Fibroblasts Via CD40-CD40L Combination in Thyroid-Associated Ophthalmopathy. Invest Ophthalmol Vis Sci 57:6123\u20136133","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1565_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000452541","volume":"40","author":"C Li","year":"2016","unstructured":"Li C, Yuan J, Zhu Y, Yang X, Wang Q, Xu J, He S, Zhang J (2016) Imbalance of Th17\/Treg in Different Subtypes of Autoimmune Thyroid Diseases. Cell Physiol Biochem 40:245\u2013252","journal-title":"Cell Physiol Biochem"},{"key":"1565_CR15","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3109\/08923973.2011.619987","volume":"34","author":"F Jadidi-Niaragh","year":"2012","unstructured":"Jadidi-Niaragh F, Mirshafiey A (2012) The deviated balance between regulatory T cell and Th17 in autoimmunity. Immunopharmacol Immunotoxicol 34:727\u2013739","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"1565_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000443828","volume":"5","author":"L Bartalena","year":"2016","unstructured":"Bartalena L, Baldeschi L, Boboridis K, Eckstein A, Kahaly GJ, Marcocci C, Perros P, Salvi M, Wiersinga WM (2016) The 2016 European Thyroid Association\/European Group on Graves\u2019 Orbitopathy Guidelines for the Management of Graves\u2019 Orbitopathy. Eur Thyroid J 5:9\u201326","journal-title":"Eur Thyroid J"},{"key":"1565_CR17","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1210\/jc.2010-1962","volume":"96","author":"S Zang","year":"2011","unstructured":"Zang S, Ponto KA, Kahaly GJ (2011) Intravenous glucocorticoids for Graves\u2019 orbitopathy: efficacy and morbidity. J Clin Endocrinol Metab 96:320\u2013332","journal-title":"J Clin Endocrinol Metab"},{"key":"1565_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa1910434","volume":"382","author":"RS Douglas","year":"2020","unstructured":"Douglas RS, Kahaly GJ, Patel A, Sile S, Thompson EHZ, Perdok R, Fleming JC, Fowler BT, Marcocci C, Marin\u00f2 M, Antonelli A, Dailey R et al (2020) Teprotumumab for the treatment of active thyroid eye disease. N Engl J Med 382:341\u2013352","journal-title":"N Engl J Med"},{"key":"1565_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41574-019-0305-4","volume":"16","author":"PN Taylor","year":"2020","unstructured":"Taylor PN, Zhang L, Lee RWJ, Muller I, Ezra DG, Dayan CM, Kahaly GJ, Ludgate M (2020) New insights into the pathogenesis and nonsurgical management of Graves orbitopathy. Nat Rev Endocrinol 16:104\u2013116","journal-title":"Nat Rev Endocrinol"},{"key":"1565_CR20","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3390\/ijms19030730","volume":"19","author":"GR Lee","year":"2018","unstructured":"Lee GR (2018) The balance of Th17 versus Treg cells in autoimmunity. Int J Mol Sci 19(3):730.\n\n\u00a0","journal-title":"Int J Mol Sci"},{"key":"1565_CR21","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41573-019-0041-4","volume":"18","author":"LMR Ferreira","year":"2019","unstructured":"Ferreira LMR, Muller YD, Bluestone JA, Tang Q (2019) Next-generation regulatory T cell therapy. Nat Rev Drug Discov 18:749\u2013769","journal-title":"Nat Rev Drug Discov"},{"key":"1565_CR22","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","volume":"20","author":"C Raffin","year":"2020","unstructured":"Raffin C, Vo LT, Bluestone JA (2020) Treg cell-based therapies: challenges and perspectives. Nat Rev Immunol 20:158\u2013172","journal-title":"Nat Rev Immunol"},{"key":"1565_CR23","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41590-018-0120-4","volume":"19","author":"M Dominguez-Villar","year":"2018","unstructured":"Dominguez-Villar M, Hafler DA (2018) Regulatory T cells in autoimmune disease. Nat Immunol 19:665\u2013673","journal-title":"Nat Immunol"},{"key":"1565_CR24","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1002\/art.34477","volume":"64","author":"M Samson","year":"2012","unstructured":"Samson M, Audia S, Janikashvili N, Ciudad M, Trad M, Fraszczak J, Ornetti P, Maillefert J-F, Miossec P, Bonnotte B (2012) Brief report: inhibition of interleukin-6 function corrects Th17\/Treg cell imbalance in patients with rheumatoid arthritis. Arthritis Rheum 64:2499\u20132503","journal-title":"Arthritis Rheum"},{"key":"1565_CR25","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.18240\/ijo.2019.12.02","volume":"12","author":"X-S Wu","year":"2019","unstructured":"Wu X-S, Lu X-L, Wu J, Ma M, Yu J, Zhang Z-Y (2019) Tocilizumab promotes corneal allograft survival in rats by modulating Treg-Th17 balance. Int J Ophthalmol 12:1823\u20131831","journal-title":"Int J Ophthalmol"},{"key":"1565_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/cei.12017","volume":"171","author":"B Pesce","year":"2013","unstructured":"Pesce B, Soto L, Sabugo F, Wurmann P, Cuchacovich M, L\u00f3pez MN, Sotelo PH, Molina MC, Aguill\u00f3n JC, Catal\u00e1n D (2013) Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patients. Clin Exp Immunol 171:237\u2013242","journal-title":"Clin Exp Immunol"},{"key":"1565_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.2331047.x","volume":"47","author":"MP Mourits","year":"1997","unstructured":"Mourits MP, Prummel MF, Wiersinga WM, Koornneef L (1997) Clinical activity score as a guide in the management of patients with Graves\u2019 ophthalmopathy. Clin Endocrinol (Oxf) 47:9\u201314","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1565_CR28","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.2147\/OPTH.S118555","volume":"10","author":"T Tsirouki","year":"2016","unstructured":"Tsirouki T, Bargiota A, Tigas S, Vasileiou A, Kapsalaki E, Giotaki Z, Asproudis I, Tsatsoulis A, Koukoulis G, Tsironi EE (2016) Clinical and imaging evaluation of the response to intravenous steroids in patients with Graves\u2019 orbitopathy and analysis on who requires additional therapy. Clin Ophthalmol Auckl NZ 10:2277\u20132289","journal-title":"Clin Ophthalmol Auckl NZ"},{"key":"1565_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17257-6","author":"T Higashiyama","year":"2017","unstructured":"Higashiyama T, Iwasa M, Ohji M (2017) Quantitative analysis of inflammation in orbital fat of thyroid-associated ophthalmopathy using MRI signal intensity.Sci Rep 7(1):16874. https:\/\/doi.org\/10.1038\/s41598-017-17257-6","journal-title":"Sci Rep"},{"key":"1565_CR30","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00234-014-1332-4","volume":"56","author":"F Tortora","year":"2014","unstructured":"Tortora F, Prudente M, Cirillo M, Elefante A, Belfiore MP, Romano F, Cappabianca S, Carella C, Cirillo S (2014) Diagnostic accuracy of short-time inversion recovery sequence in Graves\u2019 ophthalmopathy before and after prednisone treatment. Neuroradiology 56:353\u2013361","journal-title":"Neuroradiology"},{"key":"1565_CR31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1507\/endocrj.EJ16-0083","volume":"64","author":"Y He","year":"2017","unstructured":"He Y, Mu K, Liu R, Zhang J, Xiang N (2017) Comparison of two different regimens of intravenous methylprednisolone for patients with moderate to severe and active Graves’ ophthalmopathy: a prospective, randomized controlled trial. Endocr J 64:141\u2013149","journal-title":"Endocr J"},{"key":"1565_CR32","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1210\/jcem-44-1-203","volume":"44","author":"SC Werner","year":"1977","unstructured":"Werner SC (1977) Modification of the classification of the eye changes of Graves\u2019 disease: recommendations of the Ad Hoc Committee of The American Thyroid Association. J Clin Endocrinol Metab 44:203\u2013204","journal-title":"J Clin Endocrinol Metab"},{"key":"1565_CR33","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1530\/eje.0.1480491","volume":"148","author":"MF Prummel","year":"2003","unstructured":"Prummel MF, Bakker A, Wiersinga WM, Baldeschi L, Mourits MP, Kendall-Taylor P, Perros P, Neoh C, Dickinson AJ, Lazarus JH, Lane CM, Heufelder AE et al (2003) Multi-center study on the characteristics and treatment strategies of patients with Graves\u2019 orbitopathy: the first European Group on Graves\u2019 Orbitopathy experience. Eur J Endocrinol 148:491\u2013495","journal-title":"Eur J Endocrinol"},{"key":"1565_CR34","unstructured":"Ng C, Yuen H, Choi K, Chan M, Yuen K, Ng T (2005) Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves\u2019 ophthalmopathy: a preliminary study. Hong Kong Med J 11(5):322-30.PMID:16219950"},{"key":"1565_CR35","first-page":"3562","volume":"86","author":"C Marcocci","year":"2001","unstructured":"Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell\u2019Unto E, Rocchi R, Barbesino G, Mazzi B, Bartolomei MP, Lepri P, Cartei F, Nardi M et al (2001) Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe graves\u2019 ophthalmopathy: results of a prospective, single-blind randomized study. J Clin Endocrinol Metab 86:3562\u20133567","journal-title":"J Clin Endocrinol Metab"},{"key":"1565_CR36","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1530\/EJE-07-0558","volume":"158","author":"RJ van Geest","year":"2008","unstructured":"van Geest RJ, Sasim IV, Koppeschaar HPF, Kalmann R, Stravers SN, Bijlsma WR, Mourits MP (2008) Methylprednisolone pulse therapy for patients with moderately severe Graves\u2019 orbitopathy: a prospective, randomized, placebo-controlled study. Eur J Endocrinol 158:229\u2013237","journal-title":"Eur J Endocrinol"},{"key":"1565_CR37","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0889-8529(18)30485-7","volume":"16","author":"RS Bahn","year":"1987","unstructured":"Bahn RS, Gorman CA (1987) Choice of therapy and criteria for assessing treatment outcome in thyroid-associated ophthalmopathy. Endocrinol Metab Clin North Am 16:391\u2013407","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1565_CR38","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/0002-9394(69)91246-X","volume":"68","author":"SC Werner","year":"1969","unstructured":"Werner SC (1969) Classification of the eye changes of Graves\u2019 disease. Am J Ophthalmol 68:646\u2013648","journal-title":"Am J Ophthalmol"},{"key":"1565_CR39","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods San Diego Calif 25:402\u2013408","journal-title":"Methods San Diego Calif"},{"key":"1565_CR40","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.3390\/ijms20051142","volume":"20","author":"L Cari","year":"2019","unstructured":"Cari L, De Rosa F, Nocentini G, Riccardi C (2019) Context-dependent effect of glucocorticoids on the proliferation, differentiation, and apoptosis of regulatory T cells: a review of the empirical evidence and clinical applications. Int J Mol Sci 20:1142","journal-title":"Int J Mol Sci"},{"key":"1565_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01744","author":"C Strehl","year":"2019","unstructured":"Strehl C, Ehlers L, Gaber T, Buttgereit F (2019) Glucocorticoids\u2014all-rounders tackling the versatile players of the immune system. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2019.01744","journal-title":"Front Immunol"},{"key":"1565_CR42","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/all.13051","volume":"72","author":"J Banuelos","year":"2017","unstructured":"Banuelos J, Cao Y, Shin SC, Lu NZ (2017) Immunopathology alters Th17 cell glucocorticoid sensitivity. Allergy 72:331\u2013341","journal-title":"Allergy"},{"key":"1565_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0143689","volume":"10","author":"A Mathian","year":"2015","unstructured":"Mathian A, Jouenne R, Chader D, Cohen-Aubart F, Haroche J, Fadlallah J, Cla\u00ebr L, Musset L, Gorochov G, Amoura Z, Miyara M (2015) Regulatory T cell responses to high-dose methylprednisolone in active systemic lupus erythematosus. PLoS ONE 10:1\u201317","journal-title":"PLoS ONE"},{"key":"1565_CR44","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.imbio.2017.10.010","volume":"223","author":"E Ugor","year":"2018","unstructured":"Ugor E, Prenek L, Pap R, Berta G, Ernszt D, Najbauer J, N\u00e9meth P, Boldizs\u00e1r F, Berki T (2018) Glucocorticoid hormone treatment enhances the cytokine production of regulatory T cells by upregulation of Foxp3 expression. Immunobiology 223:422\u2013431","journal-title":"Immunobiology"},{"key":"1565_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3109\/03009742.2014.922214","volume":"44","author":"K Tselios","year":"2015","unstructured":"Tselios K, Sarantopoulos A, Gkougkourelas I, Boura P (2015) The influence of therapy on CD4+CD25(high)FOXP3+ regulatory T cells in systemic lupus erythematosus patients: a prospective study. Scand J Rheumatol 44:29\u201335","journal-title":"Scand J Rheumatol"},{"key":"1565_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.800","author":"X Fu","year":"2019","unstructured":"Fu X, Cai J, Li M (2019) Prednisone may rebuild the immunologic homeostasis: alteration of Th17 and Treg cells in the lymphocytes from rats\u2019 spleens after treated with prednisone-containing serum. Mol Genet Genomi c Med 7(7):e 00800. https:\/\/doi.org\/10.1002\/mgg3.800","journal-title":"Mol Genet Genomic Med"},{"key":"1565_CR47","doi-asserted-by":"publisher","first-page":"e24345","DOI":"10.1371\/journal.pone.0024345","volume":"6","author":"S Sbiera","year":"2011","unstructured":"Sbiera S, Dexneit T, Reichardt SD, Michel KD, van den Brandt J, Schmull S, Kraus L, Beyer M, Mlynski R, Wortmann S, Allolio B, Reichardt HM et al (2011) Influence of short-term glucocorticoid therapy on regulatory T cells in vivo. PLoS ONE 6:e24345","journal-title":"PLoS ONE"},{"key":"1565_CR48","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1530\/EJE-11-0879","volume":"166","author":"Y Hu","year":"2012","unstructured":"Hu Y, Tian W, Zhang L-L, Liu H, Yin G-P, He B-S, Mao X-M (2012) Function of regulatory T-cells improved by dexamethasone in Graves\u2019 disease. Eur J Endocrinol Eur Fed Endocr Soc 166:641\u2013646","journal-title":"Eur J Endocrinol Eur Fed Endocr Soc"},{"key":"1565_CR49","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/j.jaci.2018.07.019","volume":"142","author":"KJ de Castro","year":"2018","unstructured":"de Castro KJ, Knoke K, Kofler DM, Steiger J, Fabri M (2018) Glucocorticoids promote intrinsic human TH17 differentiation. J Allergy Clin Immunol 142:1669-1673.e11","journal-title":"J Allergy Clin Immunol"},{"key":"1565_CR50","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1530\/EJE-13-0611","volume":"170","author":"G Vannucchi","year":"2014","unstructured":"Vannucchi G, Covelli D, Campi I, Origo D, Curr\u00f2 N, Cirello V, Dazzi D, Beck-Peccoz P, Salvi M (2014) The therapeutic outcome of intravenous steroid therapy for active Graves\u2019 orbitopathy is influenced by the time of response but not polymorphisms of the glucocorticoid receptor. Eur J Endocrinol 170:55\u201361","journal-title":"Eur J Endocrinol"},{"key":"1565_CR51","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1600-065X.2008.00637.x","volume":"223","author":"TM Brusko","year":"2008","unstructured":"Brusko TM, Putnam AL, Bluestone JA (2008) Human regulatory T cells: role in autoimmune disease and therapeutic opportunities. Immunol Rev 223:371\u2013390","journal-title":"Immunol Rev"},{"key":"1565_CR52","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/j.1365-2362.2007.01882.x","volume":"37","author":"S-C Lin","year":"2007","unstructured":"Lin S-C, Chen K-H, Lin C-H, Kuo C-C, Ling Q-D, Chan C-H (2007) The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Eur J Clin Invest 37:987\u2013996","journal-title":"Eur J Clin Invest"},{"key":"1565_CR53","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.jaci.2018.10.015","volume":"142","author":"JH Esensten","year":"2018","unstructured":"Esensten JH, Muller YD, Bluestone JA, Tang Q (2018) Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: the next frontier. J Allergy Clin Immunol 142:1710\u20131718","journal-title":"J Allergy Clin Immunol"},{"key":"1565_CR54","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jneuroim.2019.05.004","volume":"332","author":"S Jing","year":"2019","unstructured":"Jing S, Lu J, Song J, Luo S, Zhou L, Quan C, Xi J, Zhao C (2019) Effect of low-dose rituximab treatment on T- and B-cell lymphocyte imbalance in refractory myasthenia gravis. J Neuroimmunol 332:216\u2013223","journal-title":"J Neuroimmunol"},{"key":"1565_CR55","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ophtha.2009.05.029","volume":"117","author":"KKL Chong","year":"2010","unstructured":"Chong KKL, Khanna D, Afifiyan NF, Hwang CJ, Lee DK, Chokron Garneau H, Goldberg RA, Darwin CH, Smith TJ, Douglas RS (2010) Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy. Ophthalmology 117:133","journal-title":"Ophthalmology"},{"key":"1565_CR56","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ajo.2018.07.038","volume":"195","author":"JV Perez-Moreiras","year":"2018","unstructured":"Perez-Moreiras JV, Gomez-Reino JJ, Maneiro JR, Perez-Pampin E, Romo Lopez A, Rodr\u00edguez Alvarez FM, Castillo Laguarta JM, Del Estad Cabello A, Gessa Sorroche M, Espa\u00f1a Gregori E, Sales-Sanz M, Tocilizumab in Graves Orbitopathy Study Group (2018) Efficacy of tocilizumab in patients with moderate-to-severe corticosteroid-resistant graves orbitopa. Am J Ophthalmol 195:181\u2013190","journal-title":"Am J Ophthalmol"},{"key":"1565_CR57","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/rheumatology\/ken108","volume":"47","author":"H-Y Lee","year":"2008","unstructured":"Lee H-Y, Hong Y-K, Yun H-J, Kim Y-M, Kim J-R, Yoo W-H (2008) Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus. Rheumatol Oxf Engl 47:789\u2013794","journal-title":"Rheumatol Oxf Engl"},{"issue":"195","key":"1565_CR58","first-page":"2507","volume":"2015","author":"DJ Campbell","year":"1950","unstructured":"Campbell DJ (1950) Control of regulatory T cell migration, function and homeostasis. J Immunol Baltim Md 2015(195):2507\u20132513","journal-title":"J Immunol Baltim Md"},{"key":"1565_CR59","doi-asserted-by":"publisher","first-page":"e0162306","DOI":"10.1371\/journal.pone.0162306","volume":"11","author":"T Morita","year":"2016","unstructured":"Morita T, Shima Y, Wing JB, Sakaguchi S, Ogata A, Kumanogoh A (2016) The proportion of regulatory T Cells in patients with rheum. PLoS ONE 11:e0162306","journal-title":"PLoS ONE"},{"key":"1565_CR60","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nyas.13011","volume":"1417","author":"R Bacchetta","year":"2018","unstructured":"Bacchetta R, Barzaghi F, Roncarolo M-G (2018) From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation. Ann N Y Acad Sci 1417:5\u201322","journal-title":"Ann N Y Acad Sci"},{"key":"1565_CR61","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.imbio.2018.12.002","volume":"224","author":"R Pap","year":"2019","unstructured":"Pap R, Ugor E, Litvai T, Prenek L, Najbauer J, N\u00e9meth P, Berki T (2019) Glucocorticoid hormone differentially modulates the in vitro expansion and cytokine profile of thymic and splenic Treg cells. Immunobiology 224:285\u2013295","journal-title":"Immunobiology"},{"key":"1565_CR62","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nri2785","volume":"10","author":"S Sakaguchi","year":"2010","unstructured":"Sakaguchi S, Miyara M, Costantino CM, Hafler DA (2010) FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10:490\u2013500","journal-title":"Nat Rev Immunol"},{"key":"1565_CR63","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.jaci.2004.07.014","volume":"114","author":"C Karagiannidis","year":"2004","unstructured":"Karagiannidis C, Akdis M, Holopainen P, Woolley NJ, Hense G, R\u00fcckert B, Mantel P-Y, Menz G, Akdis CA, Blaser K, Schmidt-Weber CB (2004) Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 114:1425\u20131433","journal-title":"J Allergy Clin Immunol"},{"key":"1565_CR64","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/imm.13178","volume":"160","author":"M Ono","year":"2020","unstructured":"Ono M (2020) Control of regulatory T-cell differentiation and function by T-cell receptor signalling and Foxp3 transcription factor complexes. Immunology 160:24\u201337","journal-title":"Immunology"},{"key":"1565_CR65","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/art.39031","volume":"67","author":"AP Cribbs","year":"2015","unstructured":"Cribbs AP, Kennedy A, Penn H, Amjadi P, Green P, Read JE, Brennan F, Gregory B, Williams RO (2015) Methotrexate restores regulatory T cell function through demethylation of the FoxP3 upstream enhancer in patients with rheumatoid arthritis. Arthritis Rheumatol 67(5): 1182\u20131192.https:\/\/doi.org\/10.1002\/art.39031","journal-title":"Arthritis Rheumatol"},{"key":"1565_CR66","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/ni.2402","volume":"13","author":"D Rudra","year":"2012","unstructured":"Rudra D, deRoos P, Chaudhry A, Niec RE, Arvey A, Samstein RM, Leslie C, Shaffer SA, Goodlett DR, Rudensky AY (2012) Transcription factor Foxp3 and its protein partners form a complex regulatory network. Nat Immunol 13:1010\u20131019","journal-title":"Nat Immunol"},{"key":"1565_CR67","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.imbio.2010.06.013","volume":"216","author":"C Prado","year":"2011","unstructured":"Prado C, G\u00f3mez J, L\u00f3pez P, de Paz B, Guti\u00e9rrez C, Su\u00e1rez A (2011) Dexamethasone upregulates FOXP3 expression without increasing regulatory activity. Immunobiology 216:386\u2013392","journal-title":"Immunobiology"},{"key":"1565_CR68","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/all.12840","volume":"71","author":"J Banuelos","year":"2016","unstructured":"Banuelos J, Shin S, Cao Y, Bochner BS, Morales-Nebreda L, Budinger GRS, Zhou L, Li S, Xin J, Lingen MW, Dong C, Schleimer RP et al (2016) BCL-2 protects human and mouse Th17 cells from glucocorticoid-induced apoptosis. Allergy 71:640\u2013650","journal-title":"Allergy"},{"key":"1565_CR69","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1084\/jem.20130301","volume":"211","author":"R Ramesh","year":"2014","unstructured":"Ramesh R, Kozhaya L, McKevitt K, Djuretic IM, Carlson TJ, Quintero MA, McCauley JL, Abreu MT, Unutmaz D, Sundrud MS (2014) Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids. J Exp Med 211:89\u2013104","journal-title":"J Exp Med"},{"key":"1565_CR70","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1073\/pnas.1418316112","volume":"112","author":"LP Schewitz-Bowers","year":"2015","unstructured":"Schewitz-Bowers LP, Lait PJP, Copland DA, Chen P, Wu W, Dhanda AD, Vistica BP, Williams EL, Liu B, Jawad S, Li Z, Tucker W et al (2015) Glucocorticoid-resistant Th17 cells are selectively attenuated by cyclosporine A. Proc Natl Acad Sci U S A 112:4080\u20134085","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1565_CR71","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3389\/fimmu.2018.01112","volume":"9","author":"X Wu","year":"2018","unstructured":"Wu X, Tian J, Wang S (2018) Insight into non-pathogenic Th17 cells in autoimmune diseases. Front Immunol\u00a09:1112. https:\/\/doi.org\/10.3389\/fimmu.2018.01112","journal-title":"Front Immunol"},{"key":"1565_CR72","doi-asserted-by":"publisher","first-page":"3908061","DOI":"10.1155\/2017\/3908061","volume":"2017","author":"T Kuwabara","year":"2017","unstructured":"Kuwabara T, Ishikawa F, Kondo M, Kakiuchi T (2017) The role of IL-17 and related cytokines in inflammatory autoimmune diseases. Mediators Inflamm 2017:3908061","journal-title":"Mediators Inflamm"},{"key":"1565_CR73","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nature10228","volume":"475","author":"E Esplugues","year":"2011","unstructured":"Esplugues E, Huber S, Gagliani N, Hauser AE, Town T, Wan YY, O\u2019Connor W, Rongvaux A, Van Rooijen N, Haberman AM, Iwakura Y, Kuchroo VK et al (2011) Control of TH17 cells occurs in the small intestine. Nature 475:514\u2013518","journal-title":"Nature"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-021-01565-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-021-01565-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-021-01565-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T16:31:43Z","timestamp":1675182703000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-021-01565-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,17]]},"references-count":73,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["1565"],"URL":"https:\/\/doi.org\/10.1007\/s40618-021-01565-w","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,17]]},"assertion":[{"value":"28 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Local Bioethics Committee at Wroclaw Medical University, Poland (No. KB\u2014618\/2015).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients provided informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}